Clinical Trial Update: The Effect of Atorvastatin 80 mg on Hs-CRP/Albumin Ratio in Reducing Thrombus Burden in PCI-STEMI Patients [NA]

View source ↗

Summary

A completed clinical trial assessing whether high-dose atorvastatin (80 mg) modulates the Hs-CRP/albumin ratio and thrombus burden in STEMI patients undergoing …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• Lipitor (atorvastatin)

Snippet

Sponsor: Universitas Sebelas Maret | Conditions: STEMI (STE-ACS), Primary PCI for STEMI | NA | Status: COMPLETED